Impact of Plasma-Lyte pH 7.4 on acid-base status and hemodynamics in a model of controlled hemorrhagic shock

Carregando...
Imagem de Miniatura
Citações na Scopus
28
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
NORITOMI, Danilo Teixeira
PEREIRA, Adriano Jose
REHDER, Paulo Sergio
SILVA, Eliezer
Citação
CLINICS, v.66, n.11, p.1969-1974, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: Intravenous infusion of crystalloid solutions is a cornerstone of the treatment of hemorrhagic shock. However, crystalloid solutions can have variable metabolic acid-base effects, perpetuating or even aggravating shock-induced metabolic acidosis. The aim of this study was to compare, in a controlled volume-driven porcine model of hemorrhagic shock, the effects of three different crystalloid solutions on the hemodynamics and acid-base balance. METHODS: Controlled hemorrhagic shock (40% of the total blood volume was removed) was induced in 18 animals, which were then treated with normal saline (0.9% NaCl), Lactated Ringer's Solution or Plasma-Lyte pH 7.4, in a blinded fashion (n = 6 for each group). Using a predefined protocol, the animals received three times the volume of blood removed. RESULTS: The three different crystalloid infusions were equally capable of reversing the hemorrhage-induced low cardiac output and anuria. The Lactated Ringer's Solution and Plasma-Lyte pH 7.4 infusions resulted in an increased standard base excess and a decreased serum chloride level, whereas treatment with normal saline resulted in a decreased standard base excess and an increased serum chloride level. The Plasma-Lyte pH 7.4 infusions did not change the level of the unmeasured anions. CONCLUSION: Although the three tested crystalloid solutions were equally able to attenuate the hemodynamic and tissue perfusion disturbances, only the normal saline induced hyperchloremia and metabolic acidosis.
Palavras-chave
Acidosis, Crystalloid Solution, Hyperchloremia, Hemorrhagic Shock, Strong Ion Difference
Referências
  1. Kellum JA, 2002, CRIT CARE MED, V30, P300, DOI 10.1097/00003246-200202000-00006
  2. Waters JH, 1999, CRIT CARE MED, V27, P2142, DOI 10.1097/00003246-199910000-00011
  3. Kellum JA, 2006, CHEST, V130, P962, DOI 10.1378/chest.130.4.962
  4. Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148
  5. STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444
  6. Reid F, 2003, CLIN SCI, V104, P17, DOI 10.1042/CS20020202
  7. FIGGE J, 1991, J LAB CLIN MED, V117, P453
  8. Dingley J, 1999, CRIT CARE MED, V27, P2435, DOI 10.1097/00003246-199911000-00019
  9. Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
  10. KELLUM JA, 1995, J CRIT CARE, V10, P51, DOI 10.1016/0883-9441(95)90016-0
  11. Martin G, 2002, J CARDIOTHOR VASC AN, V16, P441, DOI 10.1053/jcan.2002.125146
  12. Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A
  13. Wooten EW, 2003, J APPL PHYSIOL, V95, P2333, DOI 10.1152/japplphysiol.00560.2003
  14. Liskaser FJ, 2000, ANESTHESIOLOGY, V93, P1170, DOI 10.1097/00000542-200011000-00006
  15. Ho AMH, 2001, J TRAUMA, V51, P173, DOI 10.1097/00005373-200107000-00033
  16. Morgan TJ, 2005, CRIT CARE, V9, P204, DOI 10.1186/cc2946
  17. Hadimioglu N, 2008, ANESTH ANALG, V107, P264, DOI 10.1213/ane.0b013e3181732d64
  18. WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820
  19. Noritomi DT, 2009, CRIT CARE MED, V37, P2733, DOI 10.1097/CCM.0b013e3181a59165
  20. FERRARA A, 1990, AM J SURG, V160, P515, DOI 10.1016/S0002-9610(05)81018-9
  21. Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352
  22. Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003
  23. Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.74
  24. EINGRABER S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007
  25. Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987
  26. Healey MA, 1998, J TRAUMA, V45, P894, DOI 10.1097/00005373-199811000-00010
  27. Kellum JA, 1998, SHOCK, V9, P364, DOI 10.1097/00024382-199805000-00009
  28. Kellum JA, 2002, CRIT CARE MED, V30, P259, DOI 10.1097/00003246-200201000-00046
  29. Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008
  30. Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65
  31. SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091